TyRx Inc. launched its AIGISRX ICD, an anti-bacterial envelope developed to help reduce surgical site infections and create a stable environment for implantable cardioverter defibrillators (ICDs).
The launch of AIGISRX ICD extends TyRx’s AIGISRX CRMD (cardiac rhythm management device) platform to the implantable cardioverter defibrillator market. The AIGISRX CRMD platform also includes AIGISRX PM, the company’s anti-bacterial coated mesh designed specifically for implanted pacemakers.